Summary:
- The article discusses a new dual-action drug that shows promise in treating Alzheimer's disease by targeting the disease at its core.
- The drug, called LMTX, has been found to reduce the buildup of tau protein tangles and amyloid plaques, which are the hallmarks of Alzheimer's disease.
- The drug has demonstrated the ability to improve cognitive function and slow the progression of the disease in clinical trials, offering hope for a more effective treatment for Alzheimer's patients.